MOOD-D: Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)

Sponsor
Washington University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT00847431
Collaborator
National Institutes of Health (NIH) (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (NIH)
81
2
84
40.5
0.5

Study Details

Study Description

Brief Summary

The goal of this study is to determine the vulnerability of mood-related neurocircuitry in Parkinson Disease (PD) using deep brain stimulation of the subthalamic nucleus (STN DBS).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    81 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Mapping Mood in the Subthalamic Nucleus in PD
    Study Start Date :
    Dec 1, 2008
    Actual Primary Completion Date :
    Dec 1, 2014
    Actual Study Completion Date :
    Dec 1, 2015

    Arms and Interventions

    Arm Intervention/Treatment
    STN DBS Group

    PD patients with deep brain stimulators in the subthalamic nucleus. Subjects within this group will be placed into either a 1 contact group, or 2 contact group, depending on contact location requirements for this study.

    Control Group

    PD patients without deep brain stimulator surgery, with similar symptoms to the study group.

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      40 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria for STN-DBS subjects:
      • Age 40 or older

      • DBS STN Surgery in past 2 to 36 months

      • Ability to tolerate turning off Stimulators

      • Ability to read and comprehend questions

      • English speaking

      Exclusion Criteria for STN-DBS subjects:
      • Other severe complications post surgery: stroke, seizure, major loss of consciousness, other brain trauma/surgery, or head injuries(i.e. near drowning), encephalitis, or hydrocephalus, blindness, deafness

      • Clinically determined Dementia ( Most recent MMSE score of >24)

      Inclusion Criteria for Control subject:
      • Age 40 or older

      • Ability to read and comprehend questions

      • English speaking

      Exclusion Criteria for Control subject:
      • Other severe complications post surgery: stroke, seizure, major loss of consciousness, other brain trauma/surgery, or head injuries(i.e. near drowning), encephalitis, or hydrocephalus, blindness, deafness

      • Clinically determined Dementia ( Most recent MMSE score of >24)

      • Plans to have DBS STN surgery in the next 24 months

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Washington University School of Medicine St. Louis Missouri United States 63110
      2 University of Cincinnati, Movement Disorder Center Cincinnati Ohio United States 45267-0525

      Sponsors and Collaborators

      • Washington University School of Medicine
      • National Institutes of Health (NIH)
      • National Institute of Neurological Disorders and Stroke (NINDS)

      Investigators

      • Principal Investigator: Tamara G Hershey, PhD, Washington University School of Medicine

      Study Documents (Full-Text)

      None provided.

      More Information

      Additional Information:

      Publications

      None provided.
      Responsible Party:
      Washington University School of Medicine
      ClinicalTrials.gov Identifier:
      NCT00847431
      Other Study ID Numbers:
      • 08-0354
      • R01NS058797-05
      First Posted:
      Feb 19, 2009
      Last Update Posted:
      May 4, 2016
      Last Verified:
      May 1, 2016
      Keywords provided by Washington University School of Medicine
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of May 4, 2016